Media stories about Cyanotech (NASDAQ:CYAN) have trended somewhat positive recently, Accern Sentiment Analysis reports. The research firm identifies negative and positive news coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Cyanotech earned a news sentiment score of 0.08 on Accern’s scale. Accern also gave news stories about the biotechnology company an impact score of 45.6239257387512 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.
Cyanotech (NASDAQ:CYAN) remained flat at $$4.05 during midday trading on Friday. The company’s stock had a trading volume of 2,473 shares, compared to its average volume of 3,043. The firm has a market cap of $23.26, a PE ratio of 67.50 and a beta of 0.99. Cyanotech has a 12 month low of $3.25 and a 12 month high of $5.35. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.36 and a quick ratio of 0.72.
Cyanotech (NASDAQ:CYAN) last posted its quarterly earnings results on Monday, November 6th. The biotechnology company reported $0.08 earnings per share (EPS) for the quarter. The business had revenue of $8.06 million during the quarter. Cyanotech had a net margin of 1.11% and a return on equity of 2.06%.
Separately, ValuEngine cut shares of Cyanotech from a “hold” rating to a “sell” rating in a report on Friday, October 6th.
COPYRIGHT VIOLATION NOTICE: “Cyanotech (CYAN) Given News Impact Score of 0.08” was originally reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this piece on another website, it was illegally copied and republished in violation of international copyright & trademark laws. The original version of this piece can be accessed at https://www.dispatchtribunal.com/2018/02/03/cyanotech-cyan-given-news-impact-score-of-0-08.html.
Cyanotech Company Profile
Cyanotech Corporation is engaged in the production of natural products derived from microalgae for the nutritional supplements market. The Company’s products include Hawaiian Spirulina Pacifica and Hawaiian BioAstin. Hawaiian Spirulina Pacifica is a dietary supplement used for extra energy, a strengthened immune system, cardiovascular benefits and as a source of antioxidant carotenoids.
Receive News & Ratings for Cyanotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cyanotech and related companies with MarketBeat.com's FREE daily email newsletter.